News and Announcements
Article highlight
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Capital Insights
1
Asset over thematic: Centuria’s Andrew Essey warns against ‘blanket strategies’ as global capital eyes Australia
2
Material gains: Swinburne spin-out EntroMat takes aim at $160b global market
3
A new corridor for wealth: PanGen Capital opens institutional property to the $100k investor
4
The Concierge of Cure: How Cicada Innovations is Solving the ‘Lab-to-Bedside’ Gap
Executive Interviews
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Asset over thematic: Centuria’s Andrew Essey warns against ‘blanket strategies’ as global capital eyes Australia
Relying solely on broad macroeconomic trends is the single biggest mistake property investors make today. Centuria Capital CIO Andrew Essey explains why asset-level “lettability” always trumps the overarching sector thematic, and reveals where global institutional capital is quietly pivoting to capture high-octane returns.
Material gains: Swinburne spin-out EntroMat takes aim at $160b global market
Traditional metallurgy has hit a performance wall. Discover how Swinburne University spin-out EntroMat is leveraging physics-based AI and circular critical minerals to engineer high-entropy alloys capable of surviving the world’s most extreme industrial environments.
Capital Insights
A new corridor for wealth: PanGen Capital opens institutional property to the $100k investor
PanGen Capital has launched a new wholesale property fund designed to smash institutional barriers. By pooling capital from $100,000, the firm gives sophisticated investors direct entry into premium, unlisted real estate portfolios historically reserved for multi-billion-dollar super funds.
The Concierge of Cure: How Cicada Innovations is Solving the ‘Lab-to-Bedside’ Gap
Cicada Innovations is solving the critical “lab-to-bedside” transition that stalls many life-saving medical breakthroughs. Led by Lilly Bojarski at the Westmead Health and Innovation District, the Health Tech Hub acts as a clinical concierge—bridging the gap between brilliant laboratory science and real-world hospital workflows to help early-stage ventures commercialise, scale, and access a multi-billion dollar market.
Why the Next Solar Revolution Looks Less Like a Silicon Valley Tech Play and More Like a Newspaper Press
For over 50 years, solar energy has meant heavy silicon panels and rigid glass frames. Newcastle deep-tech startup Kardinia Energy is shattering that mold. By leveraging roll-to-roll printing presses—identical to those once used for daily newspapers—they are churning out flexible, ultra-lightweight solar mats that cost a fraction of traditional silicon, boast a 12-to-18-month ROI, and are already powering Coldplay’s world tour. Unlocking millions of square meters of unviable industrial roof space, this is the story of how an Australian company is rewriting the laws of clean energy.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
How to Raise Capital from Wholesale Investors in Australia
Raising capital from wholesale investors is the most efficient path to funding for Australian companies that want to avoid the cost, time, and regulatory burden of producing a full prospectus. Under Section 708 of the Corporations Act 2001, companies can raise capital from investors without a disclosure document, provided specific exemptions are met. This guide […]
Steve Torso: Founder of Wholesale Investor & CapitalHQ
Steve Torso is the Founder and CEO of Wholesale Investor, Australia’s leading private capital marketplace, and CapitalHQ, the AI-powered Capital Engagement Agent platform transforming how companies raise capital and manage investor relationships. Building Australia’s Private Capital Infrastructure Steve co-founded Wholesale Investor in 2008 with a clear thesis: the gap between companies seeking private capital and […]
Wholesale Investor: Australia’s Leading Private Capital Marketplace
Since 2008, Wholesale Investor has been connecting qualified investors with high-growth private companies, fund managers, and alternative investment opportunities across Australia and internationally. With a network of over 45,000 investors, the platform is the largest and most established private capital marketplace in Australasia. What is the Wholesale Investor Platform? Wholesale Investor is a business introduction […]
Wholesale Investor Tests Explained: Net Assets, Income & Product Value
Wholesale Investor Tests Explained Australian law provides multiple pathways for qualifying as a wholesale investor. Each test has different criteria, documentation requirements, and practical implications. This guide provides a detailed breakdown of every qualification test, the evidence required, and the common pitfalls to avoid. Test 1: The Net Assets Test What It Requires Net assets […]
Do I Qualify as a Wholesale Investor? The Complete Self-Assessment
Do I Qualify as a Wholesale Investor? If you are considering investing in private markets in Australia, the first question you need to answer is whether you qualify as a wholesale (or sophisticated) investor. The qualification criteria are set out in the Corporations Act 2001 and are based on financial thresholds rather than investment knowledge […]
Venture Investor Interviews
Australia’s 60,000 Business Succession Crisis: Why Good Companies Will Close Their Doors
The Australian Business Growth Fund identified approximately 162,000 privately held businesses in Australia with revenue between AUD$2 million and AUD$100 million. More than two-thirds are owned by people of retirement age. When surveyed, another two-thirds do not have a succession plan in place. The mathematics are stark. 60,000 businesses owned by someone of retirement age […]
Targeting the Untouchable: The High-Stakes Race to Outsmart ‘Invisible’ Tumors
Percheron Therapeutics is developing the drug HMBD-002 to target the VISTA protein, aiming to make previously “invisible” cancers visible to the immune system. The company is preparing for its critical Phase 2 human trials in 2026 after successful Phase 1 results showed tumor shrinkage.
The 2026 Family Office Briefing: The Great Professionalisation
The days of the family office as a “cottage industry” are over. As complexity overtakes capital, ultra-wealthy families are rapidly professionalising, shifting their focus to direct private markets, integrating AI as an operating system, and hiring non-family, institutional talent. Discover the four strategic imperatives—from navigating the $124 trillion succession crisis to adopting new governance frameworks—that are driving this era of Family Office Professionalisation in 2026.
Australia’s Trillion-Dollar Defence Tech Boom: A Call to Action for Founders
The global defence technology landscape is no longer a niche for the select few. For Australian founders, it represents a monumental, yet frequently underestimated, investment opportunity. Fuelled by escalating geopolitical tensions and a fundamental re-prioritisation of global spending, this sector is experiencing an unprecedented tailwind. According to Steve Baxter, Lead Investor at Beaten Zone Venture […]
Cryptos New Frontier: Institutionalisation, Real-World Assets, and the End of Wild West Investing
The cryptocurrency landscape, once characterised by rapid cycles and speculative frenzy, is undergoing a profound transformation. As global institutions and high-net-worth individuals increasingly look to allocate capital to digital assets, the focus is shifting towards maturity, regulatory clarity, and the integration of blockchain technology with traditional finance. A recent at the Emergence Singapore 2025 panel […]
Moving to Venture Investing 3.0
The next ten years are going to be the most disruptive – and potentially the most profitable – in the history of venture capital. Learn what technologies and techniques you need to adopt in order to become a successful, next-generation private market investor from this keynote presentation by Hatcher+ Managing Partner John Sharp. Looking for […]
Backed By Leading Investment Groups and Family Offices
